return equiti ttm
yet anoth countri add telemonitor strong fiscal third-quart
stock thought conclus
total revenu fiscal third quarter million report
constant-curr million ahead estim million
report constant currenc beat driven strong out-performance
intern gener mask continu gain telemonitor
reimburs win japan demonstr sustain above-market growth
oper margin came versu estim mainli better
control expens adjust ep
across-the-board strength quarter suggest continu gain
market share invest product portfolio pay compani
activ launch multipl updat offer recent allcal
connectpro next-gener mask togeth drive acceler
revenu growth share trade time calendar ep estim
rate stock outperform
america mask growth toughest comp year
model growth believ result line market
growth support mainten market share gain last quarter
least believ growth fourth quarter strong given easier
comp driven mask launch focu improv custom resuppli
process believ quiet current competit landscap improv resuppli
trend bolster mask growth fiscal beyond note medtrad
meet takeaway continu expect strong growth inogen
competit lag detail project mask growth year
fiscal fourth quarter estim market growth
someth view achiev beatabl given recent trend
manag note recent launch technolog upgrad
mask call quietair technolog reduc nois level mask
dba result diffus air flow believ increment
updat like help improv patient complianc drive better resuppli
manag allud product pipelin would expect
hear time
rapidli grow develop market diagnost therapeut devic treat sleep-disord
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
america devic growth easier comp came estim slowdown
growth seen second quarter note growth still line tradit market growth midsingl
digit suggest least maintain share categori lack competit updat
medtrad new gener respiron display expect near term suggest
remain forefront innov curv cloud-connect offer support share take
new patient adopt particularli compani remain early-to-mid-in cloud-connect devic adopt
unit state
manag note enter control roll-out mobi portabl oxygen concentr poc though
still given spec devic expect start launch select number account
potenti one alreadi use activox/resm product launch broadli compani
use feedback get initi roll-out better inform broader go-to-market strategi
intern report growth constant-curr devic constant-curr
mask expect report growth respect strong devic growth
driven continu benefit franc well increas demand japan mask side out-performance
driven compani on-going mask launch
franc continu sourc upsid devic growth expect could continu near
intermedi term albeit potenti lower rate compani begin face tougher comp next quarter
initi benefit franc begin take hold fourth quarter fiscal
japan revis cpap reimburs went effect april new guidelin allow reimburs
remot telemonitor substitut face face patient meet two time per quarter previous
patient reimburs met doctor person everi day japanes dme
anticip larger demand telemonitor solut increas adopt connect
believ inconveni meet person barrier widespread cpap
adopt japan telemonitor reduc burden incid sleep apnea japan
similar countri roughli devic penetr remain lower countri like
germani franc present strong long-term opportun
manag also note south korea soon begin reimburs diagnosi therapeut treatment
sleep apnea drive increas growth gener countri diseas histor
compani recent launch android patient engag app request intern updat
believ may increment help patient complianc patient receiv real-tim feedback
remind physician
mask side project report growth full fiscal report growth
fiscal fourth quarter conserv estim compani continu launch new mask
product face easier comp note compani success gain devic share countri like
franc japan improv mask complianc midterm drive mask growth
gener look fiscal fourth quarter believ growth estim prove
achiev beatabl despit modestli tougher comp given new japanes south korean
brightre revenu million fiscal third quarter grew report basi believ invest
manag made last year pay make platform even competit
marketplac drive growth brightre end-to-end solut remain best class competit moat
difficult overcom expect low-double-digit growth sustain
expect steadi cadenc softwar updat platform like recent launch connectpro roll
come month brightre work add effici profit cash gener improv patient care
hme earli feedback beta test compani new brightre analyt platform suggest test
custom alreadi seen larg improv revenu program posit initi respons
increas function updat compel hme make brightre prefer
 oper margin came versu estim mainli better sg leverag decreas
basi point year year lower expens manag comment aim grow sg half rate
revenu growth suggest midsingle-digit growth longer term believ compani continu show
leverag via sg cost reduct long term project oper margin expans basi point fiscal
basi point fiscal
fiscal two factor contribut compani tax rate first australian
legisl would implement base eros profit share bep initi calendar impact
fiscal would increas compani transact taxat australia rest global
busi second new tax law would lower compani domest effect tax rate littl
tax associ futur repatri earn manag believ piec legisl combin
put compani fiscal effect tax rate project tax rate
fiscal increas revenu target million million report previous
million report bottom line increas adjust ep previous
fiscal fourth quarter estim revenu million report versu prior expect
million report adjust ep estim versu prior estim
fiscal increas revenu target million million previous million
bottom line increas adjust ep versu previous fiscal ep flat
year-over-year mainli increas tax rate fiscal
